Additional Dosage Routes Equations

This section details the equations that define and support the Additional Dosage Routes features in GastroPlus®. See:
Intramuscular and Subcutaneous Compartments Equations
Equation 7-1: Transport for a perfusion-limited SubQ compartment between the SubQ compartment and systemic circulation
where:
Variable | Definition |
The mass of unbound drug that is in the SubQ compartment. | |
The local tissue blood flow rate. | |
The total concentration of drug in the arterial blood. | |
The total concentration of drug in the SubQ compartment. | |
The drug blood to plasma concentration ratio. | |
The partition coefficient for the drug between the SubQ and plasma. | |
The hematocrit. | |
The lymphatic flow rate as a percentage of the plasma flow rate. | |
The partition coefficient for the drug between the plasma and SubQ extracellular fluid. | |
The local clearance rate at the injection site. |
Equation 7-2: Transport for a permeability-limited SubQ compartment between the extracellular compartment and systemic circulation
Equation 7-3: Transport for a permeability-limited SubQ compartment between the extracellular compartment and the intracellular compartment
where:
Variable | Definition |
The mass of unbound drug in the extracellular space in the SubQ compartment. | |
| The total amount of drug in the intracellular space in the SubQ compartment. |
The local tissue blood flow rate. | |
The total concentration of drug in the arterial blood. | |
The total concentration of drug in the extracellular space in the SubQ compartment. | |
| The concentration of unbound drug in the extracellular space in the SubQ compartment. |
| The concentration of unbound drug in the intracellular space in the SubQ compartment. |
The drug blood to plasma concentration ratio. | |
The partition coefficient for the drug between the SubQ and plasma. | |
The hematocrit. | |
The lymphatic flow rate as a percentage of the plasma flow rate. | |
The partition coefficient for the drug between the plasma and SubQ extracellular fluid. | |
The permeability surface area parameter in the SubQ. | |
The local clearance rate in the extracellular space in the SubQ compartment. | |
The local clearance in the intracellular space in the SubQ compartment. |
Equation 7-4: Transport for a perfusion-limited IM compartment between the intramuscular compartment and systemic circulation
where:
Variable | Definition |
The mass of unbound drug that is in the IM compartment. | |
The local tissue blood flow rate. | |
The total concentration of drug in the arterial blood. | |
The total concentration of drug in the IM compartment. | |
The drug blood to plasma concentration ratio. | |
The partition coefficient for the drug between the muscle and plasma. | |
The hematocrit. | |
The lymphatic flow rate as a percentage of the plasma flow rate. | |
The partition coefficient for the drug between the plasma and SubQ extracellular fluid. | |
The local clearance rate at the injection site. |
Equation 7-5: Transport for a permeability-limited IM compartment between the extracellular compartment and systemic circulation
Equation 7-6: Transport for a permeability-limited IM compartment between the extracellular compartment and the intracellular compartment
where:
Variable | Definition |
The mass of unbound drug in the extracellular space in the IM compartment. | |
The total amount of drug in the intracellular space in the IM compartment. | |
The local tissue blood flow rate. | |
The total concentration of drug in the arterial blood. | |
The total concentration of drug in the extracellular space in the IM compartment. | |
The concentration of unbound drug in the extracellular space in the IM compartment. | |
The concentration of unbound drug in the intracellular space in the IM compartment. | |
The drug blood to plasma concentration ratio. | |
The partition coefficient for the drug between the muscle and plasma. | |
The hematocrit. | |
The lymphatic flow rate as a percentage of the plasma flow rate. | |
The partition coefficient for the drug between the plasma and muscle extracellular fluid. | |
The permeability surface area parameter in the muscle. | |
The local clearance rate in the extracellular space in the IM compartment. | |
The local clearance in the intracellular space in the IM compartment. |
Equation 7-7: Effective depot volume calculation
Equation 7-8: Change in effective depot volume with time as the result of tissue inflammation
Variable | Definition |
The effective depot volume at time t. | |
The effective depot volume at time 0, which represents the volume of the SubQ tissue compartment. | |
The magnitude of inflammation at time t as defined for the Inflammation versus Time profile. | |
A scaling factor for the Inflammation at time t. This parameter allows for a quick scaling of the entire Inflammation versus Time profile, or to assign a different magnitude of inflammation in the muscle and adipose compartments with simultaneous subcutaneous and intramuscular injection, which occurs when the injection point is between the two tissues. |
Equation 7-9: Inflammation equation parameters
where:
Variable | Definition |
The lag time allowed for delaying the inflammation. | |
User-defined constants that account for the body’s responses to the various drug formulations. |